FR2285856B1 - - Google Patents

Info

Publication number
FR2285856B1
FR2285856B1 FR7529371A FR7529371A FR2285856B1 FR 2285856 B1 FR2285856 B1 FR 2285856B1 FR 7529371 A FR7529371 A FR 7529371A FR 7529371 A FR7529371 A FR 7529371A FR 2285856 B1 FR2285856 B1 FR 2285856B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7529371A
Other languages
French (fr)
Other versions
FR2285856A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of FR2285856A1 publication Critical patent/FR2285856A1/en
Application granted granted Critical
Publication of FR2285856B1 publication Critical patent/FR2285856B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7529371A 1974-09-26 1975-09-25 GALENIC PREPARATION FOR LONG-TERM ALLOPURINOL THERAPEUTICS Granted FR2285856A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742446058 DE2446058A1 (en) 1974-09-26 1974-09-26 GALENIC PREPARATION FOR ALLOPURINOL CONTINUOUS THERAPY

Publications (2)

Publication Number Publication Date
FR2285856A1 FR2285856A1 (en) 1976-04-23
FR2285856B1 true FR2285856B1 (en) 1980-04-25

Family

ID=5926832

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7529371A Granted FR2285856A1 (en) 1974-09-26 1975-09-25 GALENIC PREPARATION FOR LONG-TERM ALLOPURINOL THERAPEUTICS

Country Status (9)

Country Link
JP (1) JPS5161622A (en)
AT (1) AT342774B (en)
BE (1) BE833797A (en)
DE (1) DE2446058A1 (en)
ES (1) ES441204A1 (en)
FR (1) FR2285856A1 (en)
GB (1) GB1464200A (en)
SE (1) SE7510752L (en)
ZA (1) ZA756096B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU191246B (en) * 1984-02-21 1987-01-28 Alkaloida Vegyeszeti Gyara,Hu Process for producing oral pharmaceutical compositions of retaed activity
GB2209669B (en) * 1987-09-11 1992-02-12 Squibb & Sons Inc Pharmaceutical composition containing high drug load and method for preparing same
FR2661611B1 (en) * 1990-05-04 1994-11-18 Theramex NOVEL PHARMACEUTICAL COMPOSITIONS BASED ON POLYCARBOPHIL AND PROCESS FOR OBTAINING SAME.
US5585115A (en) 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6395303B1 (en) 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US6471994B1 (en) 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
US6936277B2 (en) 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
US6391337B2 (en) 1995-11-15 2002-05-21 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US5733578A (en) 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US6852336B2 (en) 1995-11-15 2005-02-08 J. Rettenmaier & Soehne Gmbh + Co. Kg Directly compressible high load acetaminophen formulations
CN113081989B (en) * 2021-03-29 2022-10-21 海南普利制药股份有限公司 Allopurinol sustained release tablet

Also Published As

Publication number Publication date
JPS5161622A (en) 1976-05-28
ES441204A1 (en) 1977-03-16
SE7510752L (en) 1976-03-29
GB1464200A (en) 1977-02-09
FR2285856A1 (en) 1976-04-23
ZA756096B (en) 1976-10-27
BE833797A (en) 1976-03-25
AT342774B (en) 1978-04-25
ATA735075A (en) 1977-08-15
DE2446058A1 (en) 1976-04-08

Similar Documents

Publication Publication Date Title
AR199810A1 (en)
AU480582A (en)
AU481101A (en)
AU481663A (en)
BG19668A1 (en)
BG19764A1 (en)
BG20660A1 (en)
BG20668A2 (en)
BG20937A1 (en)
BG20947A1 (en)
BG20994A1 (en)
BG21067A1 (en)
BG21312A1 (en)
BG21341A1 (en)
BG21690A2 (en)
BG21760A1 (en)
BG22061A3 (en)
BG22084A3 (en)
BG22667A1 (en)
BG26365A3 (en)
BG26517A4 (en)
CH1378974A4 (en)
CH1666774A4 (en)
CH532175A4 (en)
CH564999A5 (en)

Legal Events

Date Code Title Description
ST Notification of lapse